Johanna Hann

Johanna has worked in the biotechnology and pharmaceutical industry since 1999 and has specialised in global regulatory affairs for the last 12 years.

Following studies in chemistry, Johanna began her career in the biotechnology industry as a synthetic organic chemist working for a biotech company in the UK.  She then relocated to Brisbane, Australia where she continued her career with a local biotech company developing strong HPLC and LC-MS method development and purification skills for a variety of molecules.  She later moved to a Brisbane-based pharmaceutical company where she worked in the Quality Control department before transferring into Regulatory Affairs in 2005.  In this role Johanna led projects to register generic products in all major markets (AU, NZ, US, EU & CA) working closely with key stakeholders from all departments.

In 2009, Johanna co-founded Pharma To Market providing regulatory consulting, pharmacovigilance and eSubmission services to companies within Australia and worldwide.  Over the last 8 years Johanna has led projects resulting in the successful registrations of NCE, NBE, biosimilar and generic products covering a wide range of therapeutic areas and dosage forms.  Having spent 3 years as a TGA external evaluator for the Office of Prescription Medicines, Johanna has excellent experience and insight into TGA’s requirements. Johanna also has 10 years’ experience preparing dossiers in eCTD and NeeS format for all major regions and is an official partner of LORENZ Life Sciences Group, developer of LORENZ docuBridge.   At Pharma To Market, Johanna strives to build long-lasting relationships with clients and partners, taking time to get to know them and their expectations.

Copyright © 2019 Pharma to Market. All Rights Reserved.

Translate »